BCP
GILD icon

Blue Chip Partners’s Gilead Sciences GILD Stock Holding History

Blue Chip Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,444
Closed -$188K – 136
2020
Q2 		$188K Buy
2,444
+22
+0.9% +$1.69K 0.04% 103
2020
Q1 		$181K Buy
+2,422
New +$167K 0.05% 101

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Blue Chip Partners's GILD Position: Q3 2020 in Review

Blue Chip Partners sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,444 shares — an estimated $188K sold.

Blue Chip Partners first reported a position in GILD in Q1 2020 and held it in 2 quarters. The position peaked at $188K in Q2 2020. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Blue Chip Partners reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Blue Chip Partners sold 2,444 Gilead Sciences shares in Q3 2020, an estimated $188K.
  • Blue Chip Partners first reported a position in Gilead Sciences in Q1 2020 and held it in 2 quarters.
  • Blue Chip Partners's Gilead Sciences position peaked at $188K in Q2 2020.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Blue Chip Partners's 13F filing for Q3 2020, filed 27 Oct 2020.